Loading...
•
Mar 31, 2021
Pulmonx Q1 2021 Earnings Report
Pulmonx reported a 7% increase in worldwide revenue, reaching $9.2 million, and a gross margin of 71.5% compared to 65.6% in the same period last year.
Key Takeaways
Pulmonx Corporation reported a 7% increase in worldwide revenue for the first quarter of 2021, totaling $9.2 million. The company experienced a gross margin of 71.5%, an increase from 65.6% in the same period last year. While U.S. revenue decreased by 5%, international revenue rose by 20%.
Worldwide revenue increased by 7% to $9.2 million in the first quarter of 2021.
Gross margin improved to 71.5% in the first quarter of 2021.
U.S. revenue decreased by 5% due to the impact of the COVID-19 pandemic.
International revenue increased by 20%, driven by a recovery of procedures in select markets.
Revenue by Geographic Location
Forward Guidance
Pulmonx is updating full year 2021 revenue to be in the range of $48 to $50 million and expects total operating expenses for the full year 2021 to remain in the range of $85 million to $90 million inclusive of stock-based compensation.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...